Monsenso (MONSO.CO) Stock Analysis & AI Equity Report

Medical - Healthcare Information Services DKK Explore free reports

Monsenso (MONSO.CO) overview

Monsenso (MONSO.CO) stock analysis and AI equity research. For the latest completed financial year, 2025, Monsenso reported revenue of DKK 8.9m and operating profit of DKK -7.7m; the year-end share price was 0.15 DKK and market capitalisation was DKK 10.0m. Monsenso is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Monsenso's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueDKK 7.0mFY 2025
Share price0.15 DKKFY 2025 year end
RevenueDKK 8.9mFY 2025
Operating profitDKK -7.7mFY 2025
Net earningsDKK -7.2mFY 2025
Market capitalisationDKK 10.0mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Monsenso

Monsenso A/S develops a digital health software platform for mental health care and research. Its cloud-based solution collects patient-reported and sensor data from smartphones and wearables, supports remote monitoring and treatment support, and gives clinicians a web portal for viewing patient information. The company also serves healthcare providers, researchers and pharmaceutical users.

Generate the Monsenso report

Monsenso is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Monsenso and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Monsenso

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.